Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, Rider JR, Fiorentino M, Sesso HD, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Nguyen PL, Sweeney CJ, Mucci LA; Transdisciplinary Prostate Cancer Partnership ToPCaP. Graff RE, et al. Among authors: jordahl km. Prostate. 2015 Jun 15;75(9):897-906. doi: 10.1002/pros.22973. Epub 2015 Mar 1. Prostate. 2015. PMID: 25728532 Free PMC article.
Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.
Yoo S, Pettersson A, Jordahl KM, Lis RT, Lindstrom S, Meisner A, Nuttall EJ, Stack EC, Stampfer MJ, Kraft P, Brown M, Loda M, Giovannucci EL, Kantoff PW, Mucci LA. Yoo S, et al. Among authors: jordahl km. Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2027-31. doi: 10.1158/1055-9965.EPI-14-0020. Epub 2014 Jun 12. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24925673 Free PMC article.
GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis.
Margalit DN, Jordahl KM, Werner L, Wang X, Gwo-Shu Lee M, Penney KL, Batista JL, Martin NE, Chan JM, Kantoff PW, Stampfer MJ, Nguyen PL, Mucci LA. Margalit DN, et al. Among authors: jordahl km. Clin Genitourin Cancer. 2015 Aug;13(4):370-377.e1. doi: 10.1016/j.clgc.2014.12.018. Epub 2015 Jan 3. Clin Genitourin Cancer. 2015. PMID: 25662905 Free PMC article.
Tumor expression of adiponectin receptor 2 and lethal prostate cancer.
Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA, Giovannucci EL, Loda M, Mucci LA, Finn S; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Rider JR, et al. Carcinogenesis. 2015 Jun;36(6):639-47. doi: 10.1093/carcin/bgv048. Epub 2015 Apr 11. Carcinogenesis. 2015. PMID: 25863129 Free PMC article.
Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer.
Hurley PJ, Sundi D, Shinder B, Simons BW, Hughes RM, Miller RM, Benzon B, Faraj SF, Netto GJ, Vergara IA, Erho N, Davicioni E, Karnes RJ, Yan G, Ewing C, Isaacs SD, Berman DM, Rider JR, Jordahl KM, Mucci LA, Huang J, An SS, Park BH, Isaacs WB, Marchionni L, Ross AE, Schaeffer EM. Hurley PJ, et al. Among authors: jordahl km. Clin Cancer Res. 2016 Jan 15;22(2):448-58. doi: 10.1158/1078-0432.CCR-15-0256. Epub 2015 Oct 7. Clin Cancer Res. 2016. PMID: 26446945 Free PMC article.
Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort.
Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Mucci LA; Transdisciplinary Prostate Cancer Partnership (ToPCaP). Thorgeirsson T, et al. Among authors: jordahl km. Carcinogenesis. 2016 Mar;37(3):262-8. doi: 10.1093/carcin/bgw001. Epub 2016 Jan 16. Carcinogenesis. 2016. PMID: 26775038 Free PMC article.
Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer.
Giunchi F, Jordahl K, Bollito E, Colecchia M, Patriarca C, D'Errico A, Vasuri F, Malvi D, Fornari A, Bonetti LR, Corti B, Papotti M, DeGiuli P, Loda M, Montironi R, Fiorentino M, Rider JR. Giunchi F, et al. Virchows Arch. 2017 Jun;470(6):711-715. doi: 10.1007/s00428-017-2123-1. Epub 2017 Apr 12. Virchows Arch. 2017. PMID: 28405833
Copy number alterations are associated with metastatic-lethal progression in prostate cancer.
Wang X, Grasso CS, Jordahl KM, Kolb S, Nyame YA, Wright JL, Ostrander EA, Troyer DA, Lance R, Feng Z, Dai JY, Stanford JL. Wang X, et al. Among authors: jordahl km. Prostate Cancer Prostatic Dis. 2020 Sep;23(3):494-506. doi: 10.1038/s41391-020-0212-8. Epub 2020 Feb 18. Prostate Cancer Prostatic Dis. 2020. PMID: 32071439 Free PMC article.
A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang V, Geybels MS, Jordahl KM, Gerke T, Hamid A, Penney KL, Markt SC, Freedman M, Pomerantz M, Lee GM, Rana H, Börnigen D, Rebbeck TR, Huttenhower C, Eeles RA, Stanford JL, Consortium P, Berndt SI, Claessens F, Sørensen KD, Park JY, Vega A, Usmani N, Mucci L, Sweeney CJ. Wang V, et al. Among authors: jordahl km. Prostate. 2021 Jul;81(10):683-693. doi: 10.1002/pros.24148. Epub 2021 May 6. Prostate. 2021. PMID: 33956343 Free PMC article.
Methylation Subtypes of Primary Prostate Cancer Predict Poor Prognosis.
Wang X, Jordahl KM, Zhu C, Livingstone J, Rhie SK, Wright JL, Grady WM, Boutros PC, Stanford JL, Dai JY. Wang X, et al. Among authors: jordahl km. Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1473-1482. doi: 10.1158/1055-9965.EPI-22-0007. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35437583 Free PMC article.
35 results